Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis
- Autores
- Pozner, Roberto Gabriel; Negrotto, Soledad; D'Atri, Lina Paola; Kotler, Mónica Lidia; Lazzari, María Angela; Gómez, Ricardo Martín; Schattner, Mirta
- Año de publicación
- 2005
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- 1. We have previously demonstrated that nitric oxide (NO) triggers CD34⁺-derived megakaryocyte apoptosis. We here show that prostacyclin (PGI₂) inhibits PAPA/NO-induced megakaryocyte death detected by fluorescent microscopy and flow cytometry. 2. The cAMP-specific phosphodiesterase inhibitor, Ro 20-1724, and the permeable analog dibutyryl-cAMP also delayed apoptosis. PGI₂ effect was fully prevented when adenylyl cyclase activity was suppressed by SQ 22536, and partially reversed by the permeable protein kinase A inhibitor PKI 14-22 amide. ELISA showed that while both PGI₂ and NO alone or synergistically raised cAMP, only NO was able to increase intracellular cGMP levels. 3. Treatment of megakaryocytes with PGI₂ abolished both basal and NO-raised cGMP levels. Addition of 8-pCPT-cGMP or activation of soluble guanylyl cyclase by BAY 41-2272 induced cell death in a concentration-dependent manner, and ODQ, an inhibitor of guanylyl cyclase, prevented both PAPA/NO- or BAY 41-2272-induced apoptosis. Specific cGMP phosphodiesterase inhibition by Zaprinast or suppression of adenylyl cyclase by SQ 22536 enhanced the PAPA/NO proapoptotic effect. 4. PGI₂ completely inhibited NO-mediated generation and the increased activity of the cleaved form of caspase-3. 5. In conclusion, our results demonstrate that contrary to their well-known direct and synergistic inhibitory effects on platelets, PGI₂ and NO regulate opposite megakaryocyte survival responses through a delicate balance between intracellular cyclic nucleotide levels and caspase-3 activity control.
Facultad de Ciencias Exactas
Instituto de Biotecnologia y Biologia Molecular - Materia
-
Ciencias Exactas
Biología
PGI₂
NO
cAMP
cGMP
caspase - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/127155
Ver los metadatos del registro completo
id |
SEDICI_7ae99008ae012641cb94df6f8ca3763b |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/127155 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosisPozner, Roberto GabrielNegrotto, SoledadD'Atri, Lina PaolaKotler, Mónica LidiaLazzari, María AngelaGómez, Ricardo MartínSchattner, MirtaCiencias ExactasBiologíaPGI₂NOcAMPcGMPcaspase1. We have previously demonstrated that nitric oxide (NO) triggers CD34⁺-derived megakaryocyte apoptosis. We here show that prostacyclin (PGI₂) inhibits PAPA/NO-induced megakaryocyte death detected by fluorescent microscopy and flow cytometry. 2. The cAMP-specific phosphodiesterase inhibitor, Ro 20-1724, and the permeable analog dibutyryl-cAMP also delayed apoptosis. PGI₂ effect was fully prevented when adenylyl cyclase activity was suppressed by SQ 22536, and partially reversed by the permeable protein kinase A inhibitor PKI 14-22 amide. ELISA showed that while both PGI₂ and NO alone or synergistically raised cAMP, only NO was able to increase intracellular cGMP levels. 3. Treatment of megakaryocytes with PGI₂ abolished both basal and NO-raised cGMP levels. Addition of 8-pCPT-cGMP or activation of soluble guanylyl cyclase by BAY 41-2272 induced cell death in a concentration-dependent manner, and ODQ, an inhibitor of guanylyl cyclase, prevented both PAPA/NO- or BAY 41-2272-induced apoptosis. Specific cGMP phosphodiesterase inhibition by Zaprinast or suppression of adenylyl cyclase by SQ 22536 enhanced the PAPA/NO proapoptotic effect. 4. PGI₂ completely inhibited NO-mediated generation and the increased activity of the cleaved form of caspase-3. 5. In conclusion, our results demonstrate that contrary to their well-known direct and synergistic inhibitory effects on platelets, PGI₂ and NO regulate opposite megakaryocyte survival responses through a delicate balance between intracellular cyclic nucleotide levels and caspase-3 activity control.Facultad de Ciencias ExactasInstituto de Biotecnologia y Biologia Molecular2005-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf283-292http://sedici.unlp.edu.ar/handle/10915/127155enginfo:eu-repo/semantics/altIdentifier/issn/0007-1188info:eu-repo/semantics/altIdentifier/pmid/15778737info:eu-repo/semantics/altIdentifier/doi/10.1038/sj.bjp.0706200info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-10-15T11:22:31Zoai:sedici.unlp.edu.ar:10915/127155Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-10-15 11:22:31.779SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
title |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
spellingShingle |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis Pozner, Roberto Gabriel Ciencias Exactas Biología PGI₂ NO cAMP cGMP caspase |
title_short |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
title_full |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
title_fullStr |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
title_full_unstemmed |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
title_sort |
Prostacyclin prevents nitric oxide-induced megakaryocyte apoptosis |
dc.creator.none.fl_str_mv |
Pozner, Roberto Gabriel Negrotto, Soledad D'Atri, Lina Paola Kotler, Mónica Lidia Lazzari, María Angela Gómez, Ricardo Martín Schattner, Mirta |
author |
Pozner, Roberto Gabriel |
author_facet |
Pozner, Roberto Gabriel Negrotto, Soledad D'Atri, Lina Paola Kotler, Mónica Lidia Lazzari, María Angela Gómez, Ricardo Martín Schattner, Mirta |
author_role |
author |
author2 |
Negrotto, Soledad D'Atri, Lina Paola Kotler, Mónica Lidia Lazzari, María Angela Gómez, Ricardo Martín Schattner, Mirta |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
Ciencias Exactas Biología PGI₂ NO cAMP cGMP caspase |
topic |
Ciencias Exactas Biología PGI₂ NO cAMP cGMP caspase |
dc.description.none.fl_txt_mv |
1. We have previously demonstrated that nitric oxide (NO) triggers CD34⁺-derived megakaryocyte apoptosis. We here show that prostacyclin (PGI₂) inhibits PAPA/NO-induced megakaryocyte death detected by fluorescent microscopy and flow cytometry. 2. The cAMP-specific phosphodiesterase inhibitor, Ro 20-1724, and the permeable analog dibutyryl-cAMP also delayed apoptosis. PGI₂ effect was fully prevented when adenylyl cyclase activity was suppressed by SQ 22536, and partially reversed by the permeable protein kinase A inhibitor PKI 14-22 amide. ELISA showed that while both PGI₂ and NO alone or synergistically raised cAMP, only NO was able to increase intracellular cGMP levels. 3. Treatment of megakaryocytes with PGI₂ abolished both basal and NO-raised cGMP levels. Addition of 8-pCPT-cGMP or activation of soluble guanylyl cyclase by BAY 41-2272 induced cell death in a concentration-dependent manner, and ODQ, an inhibitor of guanylyl cyclase, prevented both PAPA/NO- or BAY 41-2272-induced apoptosis. Specific cGMP phosphodiesterase inhibition by Zaprinast or suppression of adenylyl cyclase by SQ 22536 enhanced the PAPA/NO proapoptotic effect. 4. PGI₂ completely inhibited NO-mediated generation and the increased activity of the cleaved form of caspase-3. 5. In conclusion, our results demonstrate that contrary to their well-known direct and synergistic inhibitory effects on platelets, PGI₂ and NO regulate opposite megakaryocyte survival responses through a delicate balance between intracellular cyclic nucleotide levels and caspase-3 activity control. Facultad de Ciencias Exactas Instituto de Biotecnologia y Biologia Molecular |
description |
1. We have previously demonstrated that nitric oxide (NO) triggers CD34⁺-derived megakaryocyte apoptosis. We here show that prostacyclin (PGI₂) inhibits PAPA/NO-induced megakaryocyte death detected by fluorescent microscopy and flow cytometry. 2. The cAMP-specific phosphodiesterase inhibitor, Ro 20-1724, and the permeable analog dibutyryl-cAMP also delayed apoptosis. PGI₂ effect was fully prevented when adenylyl cyclase activity was suppressed by SQ 22536, and partially reversed by the permeable protein kinase A inhibitor PKI 14-22 amide. ELISA showed that while both PGI₂ and NO alone or synergistically raised cAMP, only NO was able to increase intracellular cGMP levels. 3. Treatment of megakaryocytes with PGI₂ abolished both basal and NO-raised cGMP levels. Addition of 8-pCPT-cGMP or activation of soluble guanylyl cyclase by BAY 41-2272 induced cell death in a concentration-dependent manner, and ODQ, an inhibitor of guanylyl cyclase, prevented both PAPA/NO- or BAY 41-2272-induced apoptosis. Specific cGMP phosphodiesterase inhibition by Zaprinast or suppression of adenylyl cyclase by SQ 22536 enhanced the PAPA/NO proapoptotic effect. 4. PGI₂ completely inhibited NO-mediated generation and the increased activity of the cleaved form of caspase-3. 5. In conclusion, our results demonstrate that contrary to their well-known direct and synergistic inhibitory effects on platelets, PGI₂ and NO regulate opposite megakaryocyte survival responses through a delicate balance between intracellular cyclic nucleotide levels and caspase-3 activity control. |
publishDate |
2005 |
dc.date.none.fl_str_mv |
2005-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Articulo http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/127155 |
url |
http://sedici.unlp.edu.ar/handle/10915/127155 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/issn/0007-1188 info:eu-repo/semantics/altIdentifier/pmid/15778737 info:eu-repo/semantics/altIdentifier/doi/10.1038/sj.bjp.0706200 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
dc.format.none.fl_str_mv |
application/pdf 283-292 |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1846064281538265088 |
score |
13.22299 |